Volatility Is Your Friend: Intra-Cellular Therapies Inc (ITCI) Is Hot Again

Intra-Cellular Therapies Inc (NASDAQ:ITCI) does about 974.38K shares in volume on a normal day but saw 696954 shares change hands in Tuesday’s trading. The company now has a market cap of 6.94B USD. Its current market price is $65.71, marking a decrease of -0.92% compared to the previous close of $66.32. The 52 week high reached by this stock is $84.89 whilst the lowest price level in 52 weeks is $45.50.

Intra-Cellular Therapies Inc (ITCI) has a 20-day trading average at $70.79 and the current price is -22.59% off the 52-week high compared with 44.42% distance from its 52-week low. The 50-day simple moving average of the closing price is $68.73 and its 200-day simple moving average is $62.69. If we look at the stock’s price movements over the week, volatility stands at 3.65%, which increases to 4.38% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 41.38 to suggest the stock is neutral.

The consensus objective for the share price is $90.89, suggesting that the stock has a potential upside of 27.7% over the period.

The company shares received a number of brokerage firm price updates over the past month, with the latest being on January 03, 2024 when Robert W. Baird initiated the stock to “Outperform” and issued a price target of $83. Morgan Stanley initiated its price target at $80.

Intra-Cellular Therapies Inc (ITCI) stock is down -7.72% over the week and 1.47% over the past month. Its price is -8.25% year-to-date and 2.00% over the past year.

To reach the target analysts have set, the stock logically needs to grow 27.7 percent from here.

The company has a return on investment of -18.11% and return on equity of -18.07%. The forward price to earnings ratio is 62.35. The beta has a value of 0.98. Price to book ratio is 10.68 and price to sales ratio is 13.50.